V Leiden and prothrombin G20210A mutations, and no antiphospholipid antibodies). Klinefelter's syndrome (47,XXY) was diagnosed in 2003 in a context of infertility; no hormonal substitution had been initiated. The patient was a smoker (15 pack years) with no history of drug or alcohol abuse.
On admission, he was afebrile, had tachycardia (104 beats/min), and had tachypnea (28 breaths/min). His weight was 96 kg, with a body mass index of 27 kg/m 2 . The blood pressure was 120/75 mmHg on the right arm. Clinical examination revealed bilateral mild gynecomastia; small, firm testes; and a tender swelling of the left leg. Unexpectedly, the left radial and the humeral pulses could not be felt, whereas other peripheral pulses were present. On repeat questioning, it was found that the patient had a recent history of pain on exercising his left arm and no measurable blood pressure on this side. D-dimers were raised at 1355 ng/mL (normal < 500 ng/mL). Other usual laboratory testings, chest X ray, and electrocardiogram showed no abnormality. Ultrasound studies revealed a thrombosis of the left gastrocnemius vein, and chest angioscan confirmed a PE in the left inferior pulmonary artery. Further laboratory test results showed a type II dyslipidemia (total cholesterol: 309 mg/dL; high-density lipoprotein cholesterol: 30 mg/dL; low-density lipoprotein
Case Report
A 34-year-old Caucasian man was presented to our emergency department with shortness of breath, chest pain, and a high suspicion of pulmonary embolism (PE). He had a long history of venous thromboembolic disease, with a first episode of PE in 1997 and 4 subsequent episodes of idiopathic deep vein thrombosis (DVT) and/or PE. Long-term oral anticoagulation was interrupted by the patient who was concerned by the risk of bleeding. There was no family history of venous or arterial thromboembolic disease. Usual thrombophilic investigations revealed no inherited or acquired prothrombotic abnormality (normal homocysteine, protein C and S, antithrombin and factor VIII levels, absence of Factor Venous thromboembolic disease is a well-documented complication of Klinefelter's syndrome, even if mechanisms underlying this prothrombotic state have not been conclusively established. On the contrary, arterial thrombosis is far less frequent, and a case of a patient with Klinefelter's syndrome presenting with simultaneous venous thrombtoembolic disease and a complete thrombosis of the left subclavian artery is presented. Elevated levels of type 1 plasminogen activator inhibitor, in the absence of other usual thrombophilic abnormalities, raise the question of the role played by this inhibitor of the fibrinolysis in the arterial and venous thromboses presented by this patient.
Keywords: Klinefelter's syndrome; venous thromboembolic disease; arterial thrombosis; type 1 plasminogen activator inhibitor cholesterol: 215 mg/dL; and triglycerides: 320 mg/dL) and confirmed peripheral hypogonadism (testosterone: 171 ng/dL; luteinizing hormone: 16.9 mIU/mL; and follicle-stimulating hormone: 10.6 mIU/mL). In addition, type 1 plasminogen activator inhibitor (PAI-1) was increased to 52 ng/mL (reference range < 43 ng/mL, enzyme-linked immunosorbent assay, TintElize; Biopool, Wicklow, Ireland). Magnetic resonance imaging of cervical vessels showed an occlusive thrombus of 2.7 cm of the proximal left subclavian artery (Figure 1 ). An extensive arterial work-up did not reveal significant peripheral or coronary atheromatosis. A carotidosubclavian transposition was successfully performed. Long-term anticoagulation with vitamin K antagonist was restarted postoperatively in combination with aspirin, a statin, and an androgenic transdermal hormonal substitution.
Discussion
A complete occlusion of a subclavian artery is an uncommon finding in young people, even in the presence of several vascular risk factors. Although venous thromboembolic disease is a well-documented complication of Klinefelter's syndrome, affecting up to one-third of the patients, 1 arterial thrombosis is far less frequent. To our knowledge, we report here the first description of simultaneous venous and arterial involvement in a patient with Klinefelter's syndrome. The mechanisms underlying this prothrombotic state have not been conclusively established, even if coinheritance of thrombophilic abnormalities has exceptionally been reported in Klinefelter's patients with DVT.
The physiological inhibitor of plasminogen activators, PAI-1, is reported to play a crucial role in the development of vascular disease, notably in hypogonadic males, 2 and its overexpression results in a hypofibrinolytic state predisposing to thrombosis. Hypogonadic males who are not on androgenreplacement therapy have elevated PAI-1 levels. 3 In this population, higher levels of tumor necrosis factor-α (TNFα) and transforming growth factor-β (TGFβ) 4 stimulate PAI-1 gene transcription through binding a TNF-responsive enhancer element, recently localized on this gene. 5 Interestingly, recent data have shown that testosterone substitution normalizes the levels of TNFα and TGFβ. 4 This case illustrates that patients with Klinefelter's syndrome have a predisposition not only to venous thrombosis but also to arterial thrombosis. We raise the question of the role played by elevated PAI-1 levels in the thrombotic tendency presented by these patients. Whether hormonal substitution reduces PAI-1 levels and prevents thrombotic complications in Klinefelter's syndrome remains to be established. For reprints and permissions queries, please visit SAGE's Web site at http://www.sagepub.com/journalsPermissions.nav.
